These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre. Stewart RD N Z Med J; 1975 Jan; 81(531):24. PubMed ID: 1055311 [No Abstract] [Full Text] [Related]
4. Clinical application of a radioreceptor assay for thyroid stimulators. Schleusener H; Kotulla P; Adlkofer F; Nussey SS; Mehdi SQ Horm Metab Res; 1975 Jul; 7(4):360-1. PubMed ID: 1173807 [No Abstract] [Full Text] [Related]
5. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis. Silverstein GE; Burke G Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002 [No Abstract] [Full Text] [Related]
6. The long-acting thyroid stimulatory: is it of importance in Graves' disease. McKenzie JM; Zakarija M; D'Amour P; Joasoo A N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442 [No Abstract] [Full Text] [Related]
11. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves' ophthalmopathy. Solomon DH; Chopra IJ; Chopra U; Smith F Trans Assoc Am Physicians; 1976; 89():159-70. PubMed ID: 828344 [No Abstract] [Full Text] [Related]
12. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis. Adams DD; Kennedy TH; Stewart RD Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686 [TBL] [Abstract][Full Text] [Related]
13. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)]. Studer H Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362 [No Abstract] [Full Text] [Related]
14. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy. Földes J; Takó J; Bános C; Gesztesi E Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524 [No Abstract] [Full Text] [Related]
15. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum]. Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360 [No Abstract] [Full Text] [Related]
16. Neonatal thyrotoxicosis with long acting thyroid stimulator-protector. O'Hearlihy C Ir Med J; 1977 Mar; 70(4):124-5. PubMed ID: 576864 [No Abstract] [Full Text] [Related]
17. [Determination of serum TSH (including analyses of long-acting thyroid stimulator and thyroid stimulating immunoglobulins)]. Mori T; Kasagi K; Endo K; Ikekubo K; Konishi J Nihon Rinsho; 1976; 34 suppl():2212-23. PubMed ID: 792508 [No Abstract] [Full Text] [Related]
18. [Radioreceptor assay of TSH]. Torizuka K; Konishi J; Endo K; Ikekubo K; Mori T Nihon Rinsho; 1976; 34(3):471-6. PubMed ID: 778435 [No Abstract] [Full Text] [Related]
19. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results]. Busnardo B; Accordi F; Debiasi S Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578 [No Abstract] [Full Text] [Related]
20. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases]. Depisch D; Höfer R; Schatz H Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238 [No Abstract] [Full Text] [Related] [Next] [New Search]